Healthcare entity

E-MOTIVE

Technology

medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Arri Coomarasamy, the most common co-covered peer. E-MOTIVE appears in 1 tracked Healthcare story from June 30, 2026. The tracked stories average 2 original sources each.

Last mentioned: Jun 30, 2026

Entity pulse

Recent coverage · E-MOTIVE

1 story
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about E-MOTIVE

medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Arri Coomarasamy, the most common co-covered peer. E-MOTIVE appears in 1 tracked Healthcare story from June 30, 2026. The tracked stories average 2 original sources each.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering E-MOTIVE. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Lancet Series on Postpartum Haemorrhage Published

    The Lancet releases a three-part series consolidating evidence on PPH, the E-MOTIVE strategy, and implementation guidance, with a special emphasis on high-burden countries like India.

  2. E-MOTIVE Trial Published

    A large cluster-randomized trial across low- and middle-income countries demonstrates that objective blood-loss measurement with a calibrated drape plus a bundled treatment package significantly reduces PPH-related severe morbidity and mortality.

Stories mentioning E-MOTIVE 1

Medical Devices Strongly positive

Simple Drape Bundle Could Cut 38% of Maternal PPH Deaths: Lancet Series

The Lancet series validates the E-MOTIVE bundle as a low-cost, scalable fix for postpartum hemorrhage, which accounts for up to 38% of maternal deaths in India. For healthcare providers, the drape-based early detection and standardized treatment protocol promise to overhaul emergency obstetric workflows and save thousands of lives.

2 sources

Source: Kirti Pandey (in) · Kirti Pandey (in)

E-MOTIVE is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.